Tissue repair research

Tissue repair research
Ordering opens later. Prices and availability are not yet published.
Ordering opens later. Prices and availability are not yet published.
Batch 100341 · Janoshik #243359
Analysed 5 November 2026. Component amounts are shown in the report; no overall purity is stated.
Original report client: Peptide Central UK.
Verification key: 3RFDG88Y8J7R
KLOW Peptide Blend 80 mg, supplied as lyophilised powder in a sealed, labelled vial for in-vitro laboratory research.
⚠ For laboratory research only. Not for use in or on humans or animals.
Images are packaging concepts, not photographed inventory.
Questions about KLOW Peptide Blend 80 mg, its specification and documentation.
All EPS FAQsKLOW lists GHK-Cu, BPC-157, TB-500 and KPV in one freeze-dried mixture. The 80 mg label refers to the combined nominal amount, not 80 mg per component.
GLOW lists GHK-Cu, BPC-157 and TB-500 without KPV. KLOW adds KPV; total masses and ingredient proportions can also differ. Compare GLOW and KLOW.
KPV 10 mg is a single-compound listing. KLOW is a mixture of four ingredients; its 80 mg total cannot be read as 80 mg of KPV.
Read the component results in the linked original report and compare its sample and batch with the material under consideration. Measured results can differ from nominal labels and do not establish the content of an unmatched stock lot.
A mixture needs analytical results that distinguish its components. A single number does not establish the identity, amount or purity of each ingredient; some reports show component quantities without an overall purity result.
The EPS listing describes a lyophilised powder blend for laboratory research. It is not supplied as a pen, finished serum or ready-to-administer solution.
Evidence for a single component does not establish the effects or safety of the four-component mixture. Read the KLOW research guide for the distinction between blend composition and evidence.
80 mg identifies the nominal mass of the complete blend per vial. It does not specify a dose, a concentration in mg/mL or a measured-content result. Ingredient quantities must be assessed separately.
This page links Janoshik report #243359, an original source report naming Peptide Central UK as its client. The reported batch is 100341. This documents the submitted sample, not a verified connection to current EPS inventory. The COA library retains the original document and verification details.
Compare the compound, chemical form, vial amount, sample description and batch or lot number. Verify the report through the issuing laboratory using its identifier and key. Use the COA verification checklist.
Check which results the original report actually provides. Individual component quantities and any purity results need separate assessment. A purity percentage does not quantify milligrams per vial or establish sterility and endotoxin results. Those require their own stated tests. The label's ordering specification is not a measured batch result.
Use the purchase section on this page for the current EPS listing status. A displayed sample price or preview basket does not establish live inventory or a confirmed order. Where the page says Price at launch, no selling price has been confirmed. Contact EPS for product enquiries.
Divide the current single-vial price by 80 for cost per labelled mg. This uses total blend mass and does not give the cost per mg of any one ingredient. Include shipping and compare the same chemical form and documentation. An unpriced size cannot establish a lowest-cost option.
Follow verified storage instructions for the exact supplied material and batch. Storage of dry powder and a prepared solution are separate questions. A general temperature range or preservative does not establish stability or an expiry. Read the storage and stability record guide.
Use a procedure validated for the exact chemical form and intended assay. Confirm solvent compatibility, concentration, container capacity and stability evidence; no universal diluent or shelf life is established here. Read the laboratory preparation guide. EPS does not provide administration or dosing instructions.
EPS delivery destinations, dispatch origin, rates and times must be confirmed in the shipping information before orders open. A country page or catalogue listing is not a delivery guarantee. Dispatch promises from another retailer do not apply to EPS.
Keep the packaging and label, photograph the damage and contact EPS with the order and batch details. Read the EPS returns and withdrawal information for the applicable process and rights. Another retailer's return deadlines do not define EPS terms.
KLOW Peptide Blend 80 mg is listed for lawful in-vitro laboratory research as research material. It is not supplied for use in or on humans or animals. EPS does not provide dosing or self-administration guidance. Read the research use statement and assess the requirements that apply to the intended laboratory work.